Breast cancer classification by proteomic technologies: Current state of knowledge
The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679 · cited 1×
“3 million women worldwide each year and accounts for about 14% of cancer-related deaths [1].”
BackgroundMolecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261 · cited 7×
“[5], it has been shown that differential gene expression patterns account for heterogeneity among breast carcinomas.”
BackgroundResultInfluentialSørlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 10,938 · cited 7×
“The profile includes overexpression of genes related to cells on the luminal side of mammary ducts, estrogen receptor (ER) and ER transcription factors [4,5].”
BackgroundResultInfluentialRepeated observation of breast tumor subtypes in independent gene expression data sets
Sørlie, T., Tibshirani, R., Parker, J., Hastie, T., Marron, J. S., Nobel, A., Deng, S., Johnsen, H., Pesich, R., Geisler, S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932692100 · Cited by 5,429 · cited 4×
“The normal breast-like subtype was located in a cluster containing normal breast and benign tumor samples and showed overexpression of genes related to adipose tissue and non-epithelial cell types in the original and subsequent validation studies [3–5].”
BackgroundInfluentialFoulkes, W. D., Smith, I. E., & Reis-Filho, J. S. (2010) · New England Journal of Medicine · doi:10.1056/nejmra1001389 · Cited by 4,157 · cited 1×
“Although basallike breast cancer and TNBC are not identical, they largely overlap in approximately 70–80% of cases in terms of morphology (ductal carcinoma of high histological grade), clinical presentation (young women), prognosis (early metastasis), association with BRCA1 gene mutation and therapeutic options (no be…”
BackgroundGoldhirsch, A., Wood, W. C., Coates, A. S., Gelber, R. D., Thürlimann, B., & Senn, H.-J. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr304 · Cited by 3,836
Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study
Carey, L. A., Perou, C. M., Livasy, C. A., Dressler, L. G., Cowan, D., Conway, K., Karaca, G., Troester, M. A., Tse, C. K., Edmiston, S., et al. (2006) · JAMA · doi:10.1001/jama.295.21.2492 · Cited by 3,819 · cited 7×
“Luminal A subtype represents 50–60% of breast carcinomas being the most common breast cancer subtype (Table 1) [9,12,25].”
BackgroundInfluentialMetastatic Behavior of Breast Cancer Subtypes
Kennecke, H., Yerushalmi, R., Woods, R., Cheang, M. C. U., Voduc, D., Speers, C. H., Nielsen, T. O., & Gelmon, K. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.9820 · Cited by 2,262
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
Cheang, M. C. U., Chia, S. K., Voduc, D., Gao, D., Leung, S., Snider, J., Watson, M., Davies, S., Bernard, P. S., Parker, J. S., et al. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp082 · Cited by 2,249 · cited 2×
“Patients with primary breast cancer of the luminal B subtype carry a slightly less favorable prognosis than those with luminal A subtype with a reported 5-year survival rate of 88% [13,26], while it is still better than that of non-luminal subtypes.”
BackgroundBreast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy
Rouzier, R., Perou, C. M., Symmans, W. F., Ibrahim, N., Cristofanilli, M., Anderson, K., Hess, K. R., Stec, J., Ayers, M., Wagner, P., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2421 · Cited by 1,891 · cited 2×
“The classification of breast cancer based on gene expression patterns has resulted into attempts to characterize clinically meaningful subgroups showing correlation with survival [7,8], disease relapse [8], site of preference of metastatic spread [9] and chemotherapy response [8,10].”
Background
Cited by
Precision medicine and radiogenomics in breast cancer: new approaches toward diagnosis and treatment
Pinker, K., Chin, J., Melsaether, A. N., Morris, E. A., & Moy, L. (2018) · Radiology · doi:10.1148/radiol.2018172171 · Cited by 275
Breast Cancer Classification Based on Proteotypes Obtained by SWATH Mass Spectrometry
Bouchal, P., Schubert, O. T., Faktor, J., Capkova, L., Imrichova, H., Zoufalova, K., Paralova, V., Hrstka, R., Liu, Y., Ebhardt, H. A., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.06.046 · Cited by 94
Covariation of Peptide Abundances Accurately Reflects Protein Concentration Differences
Zhang, B., Pirmoradian, M., Zubarev, R., & Käll, L. (2017) · Molecular & Cellular Proteomics · doi:10.1074/mcp.o117.067728 · Cited by 68
Westbrook, J. A., Wood, S. L., Cairns, D. A., McMahon, K., Gahlaut, R., Thygesen, H., Shires, M., Roberts, S., Marshall, H., Oliva, M. R., et al. (2019) · The Journal of Pathology · doi:10.1002/path.5197 · Cited by 47
Metadata
- Authors
- Lam, S. W., Jimenez, C. R., & Boven, E.
- Venue
- Cancer Treatment Reviews
- Publisher
- Elsevier BV
- Published
- 2014-02
- Volume
- 40
- Issue
- 1
- Pages
- 129-138
- ISSN
- 0305-7372 (ISSN-L)
- OpenAlex
- W1984048017
- Cited by
- 162
- References
- 67
- FWCI
- 4.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.